These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9864383)

  • 1. Transcriptional activation of CYP2C, MxA and Fas in sudden infant death syndrome.
    Beurton F; Gueret G; Horisberger M; Cheron G; Cresteil T
    Int J Mol Med; 1999 Jan; 3(1):33-9. PubMed ID: 9864383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human CYP2C locus: a prototype for intergenic and exon repetition splicing events.
    Finta C; Zaphiropoulos PG
    Genomics; 2000 Feb; 63(3):433-8. PubMed ID: 10704292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ontogenesis of CYP2C-dependent arachidonic acid metabolism in the human liver: relationship with sudden infant death syndrome.
    Tréluyer JM; Benech H; Colin I; Pruvost A; Chéron G; Cresteil T
    Pediatr Res; 2000 May; 47(5):677-83. PubMed ID: 10813596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modelling of human CYP2C subfamily enzymes CYP2C9 and CYP2C19: rationalization of substrate specificity and site-directed mutagenesis experiments in the CYP2C subfamily.
    Lewis DF; Dickins M; Weaver RJ; Eddershaw PJ; Goldfarb PS; Tarbit MH
    Xenobiotica; 1998 Mar; 28(3):235-68. PubMed ID: 9574814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of major CYP2C9 and CYP2C19 polymorphisms by fluorescence resonance energy transfer analysis.
    Borlak J; Thum T
    Clin Chem; 2002 Sep; 48(9):1592-4. PubMed ID: 12194942
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacogenetics of CYP2C subfamily in a Japanese population.
    Ieiri I; Higuchi S
    J Toxicol Sci; 1998 Jul; 23 Suppl 2():129-31. PubMed ID: 9760448
    [No Abstract]   [Full Text] [Related]  

  • 7. RNA molecules containing exons originating from different members of the cytochrome P450 2C gene subfamily (CYP2C) in human epidermis and liver.
    Zaphiropoulos PG
    Nucleic Acids Res; 1999 Jul; 27(13):2585-90. PubMed ID: 10373573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The possession of the CYP2C9*3 allele is associated with low dose requirement of acenocoumarol.
    Thijssen HH; Verkooijen IW; Frank HL
    Pharmacogenetics; 2000 Nov; 10(8):757-60. PubMed ID: 11186138
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy.
    Odani A; Hashimoto Y; Otsuki Y; Uwai Y; Hattori H; Furusho K; Inui K
    Clin Pharmacol Ther; 1997 Sep; 62(3):287-92. PubMed ID: 9333104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs.
    Klose TS; Blaisdell JA; Goldstein JA
    J Biochem Mol Toxicol; 1999; 13(6):289-95. PubMed ID: 10487415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
    Lasker JM; Wester MR; Aramsombatdee E; Raucy JL
    Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of CYP2C in the in vitro bioactivation of the contraceptive steroid desogestrel.
    Gentile DM; Verhoeven CH; Shimada T; Back DJ
    J Pharmacol Exp Ther; 1998 Dec; 287(3):975-82. PubMed ID: 9864282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes.
    Yamazaki H; Shimada T
    Arch Biochem Biophys; 1997 Oct; 346(1):161-9. PubMed ID: 9328296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 2.4-megabase physical map spanning the CYP2C gene cluster on chromosome 10q24.
    Gray IC; Nobile C; Muresu R; Ford S; Spurr NK
    Genomics; 1995 Jul; 28(2):328-32. PubMed ID: 8530044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-directed mutation studies of human liver cytochrome P-450 isoenzymes in the CYP2C subfamily.
    Veronese ME; Doecke CJ; Mackenzie PI; McManus ME; Miners JO; Rees DL; Gasser R; Meyer UA; Birkett DJ
    Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):533-8. PubMed ID: 8424795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene structure and upstream regulatory regions of human CYP2C9 and CYP2C18.
    de Morais SM; Schweikl H; Blaisdell J; Goldstein JA
    Biochem Biophys Res Commun; 1993 Jul; 194(1):194-201. PubMed ID: 8333835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the substrate specificities of human liver cytochrome P450s 2C9 and 2C18: application to the design of a specific substrate of CYP 2C18.
    Minoletti C; Dijols S; Dansette PM; Mansuy D
    Biochemistry; 1999 Jun; 38(24):7828-36. PubMed ID: 10387023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes.
    Takahashi H; Kashima T; Nomizo Y; Muramoto N; Shimizu T; Nasu K; Kubota T; Kimura S; Echizen H
    Clin Pharmacol Ther; 1998 May; 63(5):519-28. PubMed ID: 9630825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP2C19 participates in tolbutamide hydroxylation by human liver microsomes.
    Wester MR; Lasker JM; Johnson EF; Raucy JL
    Drug Metab Dispos; 2000 Mar; 28(3):354-9. PubMed ID: 10681382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of constitutive and inducible CYPs mRNA expression in the HepG2 cell line using reverse transcription-competitive PCR.
    Sumida A; Fukuen S; Yamamoto I; Matsuda H; Naohara M; Azuma J
    Biochem Biophys Res Commun; 2000 Jan; 267(3):756-60. PubMed ID: 10673364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.